| Upcoming events on PFIZER, INC. |
|
| 07/28/21 | | Interim 2021 Earnings Release |
| 07/28/21 | 10:00am | | Interim 2021 Earnings Call |
| 11/02/21 | | Q3 2021 Earnings Release (Projected) |
| 02/01/22 | | FY 2021 Earnings Release (Projected) |
|
| Past events on PFIZER, INC. |
|
| 05/06/21 | | Ex-dividend day for |
| 05/05/21 | 01:50pm | | Truist Securities Life Sciences Summit |
| 05/04/21 | 10:00am | | Q1 2021 Earnings Call |
| 05/04/21 | 06:45am | | Q1 2021 Earnings Release |
|
| Upcoming sector events for PFIZER, INC. |
|
|
| |
|
| Past sector events for PFIZER, INC. |
|
|
|
|
|
| Fiscal Period : December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
Sales
M $ |
Released
Forecast
Spread | 52 824
52 891
-0,13% | 52 546
52 524
0,04% | 53 647
53 582
0,12% | 51 750
51 807
-0,11% | 41 908
48 014
-13% |
72 838
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 20 309
20 776
-2,2% | 21 172
21 875
-3,2% | 21 814
21 615
0,92% | 21 097
22 824
-7,6% | 17 801
21 398
-17% |
27 436
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 18 480
18 819
-1,8% | 19 468
19 859
-2,0% | 20 042
19 998
0,22% | 19 420
19 883
-2,3% | 13 024
17 362
-25% |
22 678
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 8 351
11 125
-25% | 12 305
14 925
-18% | 11 885
16 386
-27% | 17 682
22 426
-21% | 7 497
13 166
-43% |
18 522
|
Net income
M $ |
Released
Forecast
Spread | 7 215
8 882
-19% | 21 308
11 574
84% | 11 153
14 121
-21% | 16 273
19 053
-15% | 9 616
16 066
-40% |
17 466
|
EPS
$ |
Released
Forecast
Spread | 1,17
1,36
-14% | 3,52
1,88
87% | 1,87
2,38
-21% | 2,87
3,40
-16% | 1,71
2,82
-39% |
2,95
| | Announcement Date | 01/31/2017 | 01/30/2018 | 01/29/2019 | 01/28/2020 | 02/02/2021 | - |
|
|
|
| Fiscal Period : December | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 |
Sales
M $ |
Released
Forecast
Spread | 13 976
13 929
0,34% | 13 118
13 012
0,82% | 13 264
13 430
-1,2% | 12 680
12 365
2,5% | 12 688
12 728
-0,31% | 12 028
11 743
2,4% | 11 801
11 553
2,1% | 12 131
12 298
-1,4% | 11 684
11 304
3,4% | 14 582
13 621
7,1% |
18 663
|
19 574
|
19 559
|
12 750
|
12 705
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 4 917
4 629
6,2% | 6 061
5 672
6,9% | 5 763
5 640
2,2% | 5 426
4 475
21% | 3 826
4 218
-9,3% | 5 539
5 220
6,1% | 5 279
5 180
1,9% | 5 595
5 090
9,9% | 3 114
3 594
-13% | 6 850
5 470
25% |
8 563
|
8 131
|
7 064
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 4 459
4 356
2,4% | 5 636
5 148
9,5% | 5 352
4 961
7,9% | 5 013
4 058
24% | 3 418
3 819
-10% | 5 135
4 535
13% | 4 791
4 175
15% | 4 333
4 505
-3,8% | 2 068
3 337
-38% | 5 624
4 659
21% |
5 495
|
5 718
|
5 290
|
|
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread |
| 4 323
3 682
17% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
M $ |
Released
Forecast
Spread | -394
2 689
-115% | 3 884
3 539
9,7% | 5 046
3 658
38% | 7 680
3 245
137% | -337
3 241
-110% | 3 401
|
| 2 194
3 215
-32% | 594
3 343
-82% | 4 877
3 829
27% |
5 241
|
5 027
|
4 576
|
|
|
EPS
$ |
Released
Forecast
Spread | -0,07
0,49
-114% | 0,68
0,60
13% | 0,89
0,65
38% | 1,36
0,53
158% | -0,06
0,53
-111% | 0,61
0,47
29% |
| 0,39
0,57
-32% | 0,10
0,40
-75% | 0,86
0,69
25% |
0,76
|
0,77
|
0,67
|
|
| | Announcement Date | 01/29/2019 | 04/30/2019 | 07/29/2019 | 10/29/2019 | 01/28/2020 | 04/28/2020 | 07/28/2020 | 10/27/2020 | 02/02/2021 | 05/04/2021 | - | - | - | - | - | |
|
|
|
|
|
AstraZeneca : GSK to boost spending power of pharma business post break-up |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year
